U.S. Tobacco Stock News

NYSE:ACEL
NYSE:ACELHospitality

Accel Entertainment (ACEL) Margin Improvement Challenges Bears Focused On Concentration Risks

Accel Entertainment (ACEL) has wrapped up FY 2025 with fourth quarter revenue of US$341.4 million and EPS of US$0.19, capping a year in which trailing twelve month revenue reached US$1.3 billion and EPS came in at US$0.61. The company has seen quarterly revenue move from US$302.2 million in Q3 2024 to US$341.4 million in Q4 2025, while quarterly EPS stepped up from US$0.06 to US$0.19 over the same stretch, setting the backdrop for investors focused on earnings growth and profit consistency...
NasdaqGS:CRWD
NasdaqGS:CRWDSoftware

CrowdStrike (CRWD) First Profitable Quarter Challenges Trailing Loss Narrative

CrowdStrike Holdings (CRWD) FY 2026 results in focus CrowdStrike Holdings (CRWD) has capped FY 2026 with fourth quarter revenue of about US$1.3 billion and basic EPS of US$0.15, alongside trailing twelve month revenue of roughly US$4.8 billion and a trailing basic EPS loss of US$0.65. The company has seen quarterly revenue move from US$1.06 billion in Q4 FY 2025 to US$1.31 billion in Q4 FY 2026, while basic EPS shifted from a loss of US$0.37 to a profit of US$0.15 over the same periods. For...
NYSE:FICO
NYSE:FICOSoftware

FICO Education Push With Banzai And NFCC Meets Premium Valuation

FICO (NYSE:FICO) has partnered with Banzai to bring credit and financial literacy education to more than 70% of U.S. K-12 schools. The collaboration gives millions of students and 150,000 teachers access to credit education tools as part of a broader financial literacy push. Separately, the National Foundation for Credit Counseling (NFCC) is expanding its work with FICO to widen access to debt relief resources that use FICO scores. For investors watching NYSE:FICO, these moves highlight how...
NasdaqGS:BCRX
NasdaqGS:BCRXBiotechs

A Look At BioCryst Pharmaceuticals (BCRX) Valuation After Its Profitability And Revenue Turnaround

BioCryst Pharmaceuticals (BCRX) drew fresh attention after reporting fourth quarter 2025 revenue of US$406.56 million and net income of US$245.85 million, compared with revenue of US$131.53 million and a net loss a year earlier. See our latest analysis for BioCryst Pharmaceuticals. The earnings swing to profitability has coincided with a 29.26% 1 month share price return and a 14.27% year to date share price return. However, the 5 year total shareholder return of a 37.03% decline shows longer...
NasdaqGS:CCOI
NasdaqGS:CCOITelecom

A Look At Cogent Communications Holdings (CCOI) Valuation After Recent Share Price Volatility

Event context and recent stock moves Cogent Communications Holdings (CCOI) has been drawing attention after recent share price swings, with the stock showing a 6.7% move over the past day and a 24.9% change over the past week. Those short term moves sit alongside a month decline of 6.6% and a past 3 months gain of 23.1%, while the 1 year total return stands at a 64.9% decline, giving investors mixed signals to assess. See our latest analysis for Cogent Communications Holdings. At a share...
NasdaqGM:ACNT
NasdaqGM:ACNTChemicals

Ascent Industries ACNT Persistent Losses Challenge Bullish Narratives Despite Premium Price To Sales Multiple

Ascent Industries FY 2025 earnings snapshot Ascent Industries (ACNT) closed out FY 2025 with Q4 revenue of US$18.8 million and a basic EPS loss of US$0.11, while trailing 12 month EPS stood at a loss of US$0.58 on revenue of US$74.9 million. The company has seen quarterly revenue move from US$40.7 million in Q4 FY 2024 to US$18.8 million in Q4 FY 2025, alongside basic EPS shifting from a profit of US$0.01 to a loss of US$0.11. This keeps the focus firmly on how efficiently each dollar of...
OTCPK:FTCO
OTCPK:FTCOMetals and Mining

Fortitude Gold (OTCPK:FTCO) Q3 Profit Challenges Bearish Loss Narratives

Fortitude Gold (FTCO) has reported its FY 2025 third quarter with revenue of US$4.7 million, basic EPS of US$0.0096 and net income of US$0.2 million. Trailing 12 month figures sit at US$25.4 million in revenue and a net loss of US$0.5 million with basic EPS at US$0.021. Over recent quarters in FY 2025, revenue has moved from US$6.5 million in Q1 to US$4.9 million in Q2, and EPS has shifted from US$0.0517 in Q1 to US$0.0350 in Q2. Together, these figures give a clearer sense of how the income...
NYSE:KN
NYSE:KNElectronic

Assessing Knowles (KN) Valuation After Strong Recent Share Price Momentum

Why Knowles Is On Investors’ Radar Now Knowles (KN) has drawn fresh attention after recent share price moves, with the stock up over the month and the past 3 months, prompting investors to reassess how its current valuation lines up with fundamentals. See our latest analysis for Knowles. The recent 1 day share price return of 1.37% comes after a weaker 7 day share price return of a 6.53% decline. However, the year to date share price return of 21.28% and 1 year total shareholder return of...
NasdaqGS:VNET
NasdaqGS:VNETIT

Assessing VNET Group (NasdaqGS:VNET) Valuation After Choppy Recent Share Price Performance

Recent performance snapshot VNET Group (NasdaqGS:VNET) has seen mixed share price moves recently, with a 4.1% gain over the past day, a 13.0% decline over the past week, and a 6.0% decline over the past month. Over a longer horizon, the stock shows a 15.9% gain in the past 3 months and a 12.6% gain year to date. The 1 year total return reflects a 17.7% decline, and the 5 year total return reflects a 69.4% decline. See our latest analysis for VNET Group. VNET Group’s recent share price moves...
NasdaqGS:WEYS
NasdaqGS:WEYSRetail Distributors

Weyco Group TTM Margin Decline Reinforces Bearish Profitability Narratives

Weyco Group (WEYS) has wrapped up FY 2025 with fourth quarter revenue of US$76.8 million and basic EPS of US$0.92, alongside net income excluding extra items of US$8.7 million, setting the tone for how the full year is being judged. Over recent quarters the company has seen revenue move from US$80.5 million and EPS of US$1.05 in Q4 2024 to US$73.1 million and US$0.70 in Q3 2025, before landing at the latest levels. This gives investors a clear view of how the top line and EPS have tracked...
NasdaqGM:EYPT
NasdaqGM:EYPTPharmaceuticals

Is It Too Late To Consider EyePoint (EYPT) After A 1‑Year Surge And DCF Upside?

If you are wondering whether EyePoint's share price still reflects fair value after a strong run, you are not alone. This article is here to help you size that up clearly. The stock last closed at US$18.00, with returns of 1.4% over 7 days, 35.4% over 30 days, 3.0% year to date, 173.6% over 1 year, a gain of around 7x over 3 years, and 72.2% over 5 years. Recent news coverage around EyePoint has focused on its position in ophthalmology and its pipeline, which has kept investor attention on...
NasdaqGS:FTRE
NasdaqGS:FTRELife Sciences

Is Fortrea Holdings (FTRE) Now An Opportunity After A 38.4% Share Price Slide?

If you are wondering whether Fortrea Holdings' current share price matches its underlying worth, you are not alone. This article will walk through what the numbers actually say about value. Over the past month the stock has seen a sharp 38.4% decline, following a relatively small 0.4% gain over the last 7 days and a 4.7% decline over the past year. This naturally raises questions about whether risk perceptions or return expectations have shifted. Recent news coverage has largely focused on...
NasdaqCM:PGY
NasdaqCM:PGYSoftware

Pagaya Technologies (PGY) Swing To Q4 Profit Tests Bearish Profitability Narratives

Pagaya Technologies (NasdaqCM:PGY) FY 2025 earnings snapshot Pagaya Technologies (NasdaqCM:PGY) has capped FY 2025 with fourth quarter revenue of US$334.8 million and basic EPS of US$0.40, alongside net income of US$33.0 million. The trailing 12 month line shows revenue of about US$1.3 billion and EPS of US$0.99. The company has seen quarterly revenue move from US$279.4 million and a basic EPS loss of US$3.20 in Q4 2024 to US$334.8 million and basic EPS of US$0.40 in Q4 2025, with net income...
NYSE:BCO
NYSE:BCOCommercial Services

Brink’s (BCO) Valuation Check As Shares Pause After Strong One Year Return

Why Brink's Stock Is On Investors' Radar Brink's (BCO) shares were recently trading around $123.68, following a mixed stretch that included a 1 day decline and weaker week and month returns, even as past 3 months and 1 year performance remain positive. See our latest analysis for Brink's. Recent trading has cooled slightly, with a 7 day share price return of a 4.55% decline and a 30 day share price return of a 3.88% decline, yet the 1 year total shareholder return of 43.52% keeps Brink's...
NYSE:MEC
NYSE:MECMachinery

Mayville Engineering Company MEC TTM Loss Challenges Bullish Profitability Narratives

Mayville Engineering Company (MEC) has capped FY 2025 with fourth quarter revenue of US$134.3 million and a basic EPS loss of US$0.21, alongside trailing twelve month revenue of US$546.5 million and a TTM basic EPS loss of US$0.40. The company has seen quarterly revenue move from US$135.4 million and basic EPS of roughly breakeven in Q1 2025 to US$144.3 million and a loss of US$0.13 in Q3 2025, before settling at Q4’s US$134.3 million and US$0.21 loss per share. This sets up a results season...
NYSE:NRP
NYSE:NRPOil and Gas

A Look At Natural Resource Partners (NRP) Valuation After Special Cash Distribution And Q4 2025 Earnings

Why Natural Resource Partners' Latest Payout and Earnings Matter Natural Resource Partners (NRP) paired its fourth quarter 2025 earnings release with a special cash distribution, giving investors fresh information on both current profitability and the partnership's approach to returning cash. See our latest analysis for Natural Resource Partners. NRP's special cash distribution and Q4 2025 results landed after a strong run, with the latest share price at $119.50 and a 90 day share price...
NYSE:UNF
NYSE:UNFCommercial Services

Is UniFirst (UNF) Pricing Reflect Recent Gains And The Cintas Cash Offer?

If you are wondering whether UniFirst's current share price really lines up with its underlying worth, this article will walk through the key numbers and what they might mean for you. The stock recently closed at US$231.26, with returns of 11.2% over 30 days, 19.4% year to date, and 10.7% over 1 year, after a 0.7% decline in the last week and a 7.2% loss over 5 years. These mixed returns over different time frames give investors a reason to step back and think carefully about what is already...
NYSE:BGS
NYSE:BGSFood

B&G Foods (BGS) TTM Loss Of US$43.3 Million Tests Bullish Turnaround Narratives

B&G Foods FY 2025 Results: Weak EPS, Soft Margins Keep Profitability Under Pressure B&G Foods (BGS) has capped FY 2025 with fourth quarter revenue of US$539.6 million and a basic EPS loss of US$0.19, keeping the full year in loss-making territory. The company has seen quarterly revenue move from US$551.6 million in Q4 2024 to US$539.6 million in Q4 2025. Basic EPS shifted from a Q4 2024 loss of US$2.81 to a Q4 2025 loss of US$0.19, and trailing twelve month EPS for Q4 2025 stands at a loss of...
NasdaqGS:OTEX
NasdaqGS:OTEXSoftware

A Look At OpenText (NasdaqGS:OTEX) Valuation As Buybacks Rise And Vertica Business Is Sold

Share buyback expansion and Vertica sale put capital return in focus Open Text (OTEX) expanded its FY26 share repurchase authorization to US$500 million and agreed to sell its Vertica analytics database business for US$150 million, moves that put capital return and portfolio focus in the spotlight. See our latest analysis for Open Text. At a share price of US$25.06, Open Text has seen a 2.37% 7 day share price return and a 25.79% 90 day share price decline, while the 1 year total shareholder...
NasdaqGS:MGRC
NasdaqGS:MGRCTrade Distributors

Assessing McGrath RentCorp (MGRC) Valuation After Q4 2025 Growth Guidance And Dividend Increase

What the latest earnings tell you about McGrath RentCorp McGrath RentCorp (MGRC) drew fresh attention after reporting fourth quarter 2025 results with higher quarterly revenue and net income year over year, alongside 2026 revenue guidance and a higher quarterly dividend. For the fourth quarter of 2025, the company reported sales of US$213.77 million and total revenue of US$256.76 million. Net income for the quarter was US$49.83 million, with basic and diluted earnings per share from...
NYSE:GATX
NYSE:GATXTrade Distributors

How Investors Are Reacting To GATX (GATX) Buyback, Dividend Hike And Stronger 2025 Earnings

GATX Corporation recently reported its full-year 2025 results, showing higher sales of US$1,486.2 million, revenue of US$1,740.4 million, net income of US$333.3 million, and increased earnings per share, alongside a new US$300 million share repurchase authorization and a US$0.66 quarterly dividend declared in February 2026. Together, the stronger profitability, fresh buyback plan, higher dividend, and 2026 earnings guidance of US$9.50–US$10.10 per diluted share highlight management’s...
NasdaqCM:CXDO
NasdaqCM:CXDOIT

Crexendo (CXDO) Margin Expansion To 7.4% Puts Bullish Profitability Narrative To The Test

Crexendo (CXDO) has rounded out FY 2025 with Q4 revenue of US$18.1 million, basic EPS of US$0.04 and net income of US$1.2 million, capping a year in which trailing twelve month revenue reached US$68.2 million and EPS came in at US$0.17. The company has seen quarterly revenue move from US$16.1 million in Q1 2025 to US$18.1 million in Q4, while basic EPS ranged from US$0.04 to US$0.05 across the year. Trailing net profit margin was described as improving from 2.8% to 7.4% over the last 12...
NYSE:APH
NYSE:APHElectronic

Amphenol Deepens AI Datacenter Role With CCS Deal And Nvidia Ties

Amphenol (NYSE:APH) is expanding its AI datacenter connectivity footprint through the acquisition of CommScope's CCS division. The company is aligning its high speed connectivity solutions with Nvidia Rubin platforms and AI focused components. For investors watching AI infrastructure, Amphenol sits at an intersection between chips and the physical hardware that links them together. The stock trades at $132.75 and has returned 106.7% over the past 1 year. Over longer periods such as 3 and 5...
NasdaqGM:ATAI
NasdaqGM:ATAIPharmaceuticals

Is It Time To Reassess AtaiBeckley (ATAI) After Its Recent Share Price Swings?

If you are wondering whether AtaiBeckley at US$3.69 is priced for its story or for its fundamentals, you are in the right place. The share price has been volatile recently, with a 15.6% decline over the last 7 days, a 1.9% decline over 30 days, a 4.7% decline year to date, but a 137.3% return over the past year and a 144.4% return over 3 years. Recent coverage around AtaiBeckley has focused on its position in the pharmaceuticals and biotech space, as well as ongoing interest from investors...